06 September 2012

Solvay investing over EUR 10 million to expand capacity at its plant in Salindres, France

06 September 2012 - Solvay announced today it is doubling the production capacity for specialty fluorinated aliphatic derivatives at its plant in Salindres, France, to keep up with the growing demand in strategic markets, such as energy storage, electronics and pharmaceuticals. The Group is investing over EUR 10 million in the plant to double the capacity of the fluorinated aliphatic derivatives production line. The project’s first stage is currently underway and the first additional volumes will be available this month. 

The Group decided to double production capacity for triflic acid and triflic anhydride (TA, TAA), as well as for Lithium bis(trifluoromethanesulfonyl)imide (LiTFSI), to meet the rapidly expanding requirements of electronic applications (such as antistatic applications for flat screens, ionic liquids and liquid crystals), the battery market (for automobiles and computers) and the pharmaceuticals market. 

This capacity expansion is strengthening the role of our Salindres plant as a major production site for innovative fluorinated aliphatic derivatives,” commented Alessandro Chiovato, General Manager of the Crop Protection, Health & Electronics business at Solvay's Global Business Unit Rhodia Aroma Performance. “It will bring us in a better position to support the growth of our customers in all regions,” he added. 

SOLVAY is an international chemical Group committed to sustainable development with a clear focus on innovation and operational excellence. It is realizing over 90% of its sales in markets where it is among the top 3 global leaders. Solvay offers a broad range of products that contribute to improving the quality of life and the performance of its customers in markets such as consumer goods, construction, automotive, energy, water and environment, and electronics. The Group is headquartered in Brussels, employs about 31,000 people in 55 countries and generated EUR 12.7 billion in net sales in 2011 (pro forma). 

Source: Solvay